Company Profile
GlaxoSmithKline
Company Overview
We are a science-led global healthcare company. We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 84 manufacturing sites in 36 countries and large R&D centres in the UK, USA, Spain, Belgium and China.
Our Pharmaceuticals business develops and makes medicines to treat a broad range of acute and chronic diseases. Our portfolio is made up of both patent-protected and off patent medicines. Our Vaccines business is one of the largest in the world, producing paediatric and adult vaccines against a range of infectious diseases. In 2014, we distributed more than 800 million doses to 170 countries, of which over 80% were supplied to developing countries. Our Consumer Healthcare business develops and markets a range of products in the areas of: Pain Relief, Respiratory, Oral Health, Nutrition/Gastro Intestinal and Skin Health. These include a number of well-known global brands such as Sensodyne, Parodontax, Poligrip, Voltaren, Panadol, Otrivin and Theraflu.
Company History
GlaxoSmithKline started operations on 1 January 2001 following the merger of GlaxoWellcome plc and SmithKline Beecham plc, but our combined histories go back much further than that.
Learn more about our collective 150+ year history at http://www.gsk.com/en-gb/about-us/our-history/